Also

Watson Pharmaceuticals Inc. of Corona agreed to buy four headache medicines from Novartis for $178 million as the maker of generic and brand-name drugs adds to its line of specialty pain treatments. Watson would gain the Fiorinal and Fioricet product lines used to treat tension headaches.